140 related articles for article (PubMed ID: 9407571)
1. Surfactant therapy improves pulmonary function in infants with Pneumocystis carinii pneumonia and acquired immunodeficiency syndrome.
Creery WD; Hashmi A; Hutchison JS; Singh RN
Pediatr Pulmonol; 1997 Nov; 24(5):370-3. PubMed ID: 9407571
[TBL] [Abstract][Full Text] [Related]
2. Improvement of pulmonary gas exchange after surfactant replacement in rats with Pneumocystis carinii pneumonia.
Eijking EP; van Daal GJ; Tenbrinck R; Sluiters JF; Hannappel E; Erdmann W; Lachmann B
Adv Exp Med Biol; 1992; 316():293-8. PubMed ID: 1288089
[TBL] [Abstract][Full Text] [Related]
3. Use of natural surfactant in an HIV-infected infant with Pneumocystis carinii pneumonia.
Marriage SC; Underhill H; Nadel S
Intensive Care Med; 1996 Jun; 22(6):611-2. PubMed ID: 8814483
[No Abstract] [Full Text] [Related]
4. Surfactant improves oxygenation in infants and children with pneumonia and acute respiratory distress syndrome.
Herting E; Möller O; Schiffmann JH; Robertson B
Acta Paediatr; 2002; 91(11):1174-8. PubMed ID: 12463314
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary surfactant in patients with Pneumocystis pneumonia and acquired immunodeficiency syndrome.
Schmidt R; Markart P; Ruppert C; Temmesfeld B; Nass R; Lohmeyer J; Seeger W; Günther A
Crit Care Med; 2006 Sep; 34(9):2370-6. PubMed ID: 16849999
[TBL] [Abstract][Full Text] [Related]
6. Surfactant therapy for acute lung injury and acute respiratory distress syndrome.
Raghavendran K; Willson D; Notter RH
Crit Care Clin; 2011 Jul; 27(3):525-59. PubMed ID: 21742216
[TBL] [Abstract][Full Text] [Related]
7. Effect of surfactant replacement on Pneumocystis carinii pneumonia in rats.
Eijking EP; van Daal GJ; Tenbrinck R; Luijendijk A; Sluiters JF; Hannappel E; Lachmann B
Intensive Care Med; 1991; 17(8):475-8. PubMed ID: 1797892
[TBL] [Abstract][Full Text] [Related]
8. Corticosteroids improve survival of children with AIDS and Pneumocystis carinii pneumonia.
Sleasman JW; Hemenway C; Klein AS; Barrett DJ
Am J Dis Child; 1993 Jan; 147(1):30-4. PubMed ID: 8093422
[TBL] [Abstract][Full Text] [Related]
9. Pneumocystis carinii pneumonia in human immunodeficiency virus-infected infants and children.
Goodwin SD
Pharmacotherapy; 1993; 13(6):640-6. PubMed ID: 8302691
[TBL] [Abstract][Full Text] [Related]
10. A shared protocol for porcine surfactant use in pediatric acute respiratory distress syndrome: a feasibility study.
Wolfler A; Piastra M; Amigoni A; Santuz P; Gitto E; Rossetti E; Tinelli C; Montani C; Savron F; Pizzi S; D'amato L; Mondardini MC; Conti G; De Silvestri A
BMC Pediatr; 2019 Jun; 19(1):203. PubMed ID: 31215483
[TBL] [Abstract][Full Text] [Related]
11. Pneumocystis carinii pneumonia in Malawian children.
Kamiya Y; Mtitimila E; Graham SM; Broadhead RL; Brabin B; Hart CA
Ann Trop Paediatr; 1997 Jun; 17(2):121-6. PubMed ID: 9230974
[TBL] [Abstract][Full Text] [Related]
12. Pneumocystis carinii pneumonia in South African children infected with human immunodeficiency virus.
Zar HJ; Dechaboon A; Hanslo D; Apolles P; Magnus KG; Hussey G
Pediatr Infect Dis J; 2000 Jul; 19(7):603-7. PubMed ID: 10917216
[TBL] [Abstract][Full Text] [Related]
13. Pneumocystis carinii in Africa: an emerging pathogen?
Russian DA; Kovacs JA
Lancet; 1995 Nov; 346(8985):1242-3. PubMed ID: 7475709
[TBL] [Abstract][Full Text] [Related]
14. Surfactant adjunctive therapy for Pneumocystis carinii pneumonitis in an infant with acute lymphoblastic leukaemia.
Slater AJ; Nichani SH; Macrae D; Wilkinson KA; Novelli V; Tasker RC
Intensive Care Med; 1995 Mar; 21(3):261-3. PubMed ID: 7790617
[TBL] [Abstract][Full Text] [Related]
15. The role of surfactant treatment in preterm infants and term newborns with acute respiratory distress syndrome.
Wirbelauer J; Speer CP
J Perinatol; 2009 May; 29 Suppl 2():S18-22. PubMed ID: 19399004
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. Pneumocystis carinii Pneumonia Prophylaxis Evaluation Working Group.
Simonds RJ; Lindegren ML; Thomas P; Hanson D; Caldwell B; Scott G; Rogers M
N Engl J Med; 1995 Mar; 332(12):786-90. PubMed ID: 7862183
[TBL] [Abstract][Full Text] [Related]
17. Pneumocystis carinii pneumonia in Zimbabwe.
Malin AS; Gwanzura LK; Klein S; Robertson VJ; Musvaire P; Mason PR
Lancet; 1995 Nov; 346(8985):1258-61. PubMed ID: 7475717
[TBL] [Abstract][Full Text] [Related]
18. Exosurf rescue surfactant improves high ventilation-perfusion mismatch in respiratory distress syndrome.
Billman D; Nicks J; Schumacher R
Pediatr Pulmonol; 1994 Nov; 18(5):279-83. PubMed ID: 7898965
[TBL] [Abstract][Full Text] [Related]
19. Acute respiratory failure following HAART introduction in patients treated for Pneumocystis carinii pneumonia.
Wislez M; Bergot E; Antoine M; Parrot A; Carette MF; Mayaud C; Cadranel J
Am J Respir Crit Care Med; 2001 Sep; 164(5):847-51. PubMed ID: 11549544
[TBL] [Abstract][Full Text] [Related]
20. 1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. National Pediatric and Family HIV Resource Center and National Center for Infectious Diseases, Centers for Disease Control and Prevention.
MMWR Recomm Rep; 1995 Apr; 44(RR-4):1-11. PubMed ID: 7565543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
